ATRIANCE

Google image searchProduct monograph

Active ingredient

nelarabine, 5 MG/ML

DIN: 02299925

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription

Company: SANDOZ CANADA INCORPORATED

Date: 30-NOV-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01B — ANTIMETABOLITES (ATC, ATC/DDD)
• L01BB — Purine analogues (ATC, ATC/DDD)
• L01BB07 — NELARABINE (ATC/DDD)

Reference brand drug: Atriance

External Links for Atriance

Search on Google

• Atriance side effects
• Atriance dosage
• nelarabine side effects
• nelarabine dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find atriance photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.